NUS - Nu Skin Enterprises, Inc.
| Previous Close | 49.99 |
| Open | 50.10 |
| Bid | 49.74 x 900 |
| Ask | 49.77 x 1000 |
| Day's Range | 49.53 - 50.30 |
| 52 Week Range | 44.36 - 88.68 |
| Volume | 428,017 |
| Avg. Volume | 684,229 |
| Market Cap | 2.755B |
| Beta (3Y Monthly) | 0.67 |
| PE Ratio (TTM) | 23.04 |
| EPS (TTM) | 2.16 |
| Earnings Date | Apr 30, 2019 |
| Forward Dividend & Yield | 1.48 (3.09%) |
| Ex-Dividend Date | 2019-02-22 |
| 1y Target Est | 71.38 |
- InvestorPlace•2 days ago
3 Personal Products Stocks to Revitalize Your Portfolio
In a trading world where investors seek the latest technology or the newest trend, personal products stocks tend to receive less attention. As an older industry which mostly produces commoditized products, investment interest in this sector tends to revolve around preserving existing wealth or generating dividend income. * 7 Stocks to Buy for Spring Season Growth Despite the perception, these firms may receive more attention as they innovate on product development or marketing. Also, a growing presence in emerging markets has also bolstered these consumer staples stocks. Although many personal products stocks could bring opportunity, these three appear especially well-positioned to profit investors:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Herbalife (HLF)Source: Aybek Erkinov via FlickrOne can argue that Herbalife (NYSE:HLF) has become better-known for hedge fund interest than what the firm produces. However, with Carl Icahn finally winning on his long bet against short-seller Bill Ackman, traders can evaluate HLF stock on sales and profit growth.The Cayman Islands-based nutrition company makes products for nutrition, energy, sports and fitness. However, its weight management segment drives more than 50% of its revenue. Though weight management encompasses multiple products, the division centers on its original product, protein shake. This Formula 1 shake is a soy-based product marketed as a "meal replacement." The company sells its product directly to the public via multi-level marketing.Unlike most personal products stocks, HLF acts as more of a growth equity. While it does not pay a dividend, it has begun to post improving growth numbers. After stagnating in the middle of the decade, revenues again started to increase in 2018. Revenue growth seems to have returned as Wall Street predicts a 6.1% increase for this year and 6.6% growth in 2020.As a result, profit increases have returned to double-digit levels, with earnings rising by 10.1% this year. This takes the forward P/E ratio to just under 14.4.HLF stock can rise, the question is how much? Herbalife currently trades at almost $53 per share. The one point of concern is it appears to have become stuck in a range. Since last August, it has twice pulled back from the low $60s per share level. I think the improving profit outlook can at least take it back to that level. However, it will need to break out of this range to sustain a longer-term upward trend. Nu Skin Enterprises (NUS)Nu Skin Enterprises (NYSE:NUS) is a multilevel marketing company who produces and sells both dietary supplements and personal care products. They market under the Nu Skin and Pharmanex brand names.The Provo, Utah-based firm operates in about 50 markets worldwide. According to the company's 10-K, they derive about 88% of their revenue from outside the U.S. Its largest market, mainland China, accounts for around 33% of that revenue.Like most personal products stocks, NUS stock pays a dividend. The current annual payout of $1.48 per share has increased every year since 2001. For new shareholders, it also yields around 2.9%, well above S&P 500 averages.A falling stock price may explain the relatively high yield. Over the last six months, the equity has lost over 40% of its value. This decline stems from its significant presence in China and investigations. Chinese authorities allege firms such as Nu Skin engaged in the unlawful promotion of health and wellness products. In early January, China instituted a 100-day ban on business meetings.The uncertainty surrounding this probe has hammered NUS stock. Consequently, investors may have a buying opportunity. NUS stock now trades at a forward P/E ratio of 11.6. Equities forecasted to increase profits by an average of 11.35% per year over the next five years rarely trade at such a low multiple. * 10 S&P 500 Stocks to Weather the Earnings Storm The tenuous situation in China adds to the risk of NUS stock. For this reason, it might make sense to wait or to buy only for the dividend. However, I think once the current crackdown ends, investors will hold a low-priced, high-growth stock with a generous payout. Unilever (UL, UN)Investors often confuse the stocks of London-based Unilever PLC (NYSE:UL) and Unilever N.V. (NYSE:UN) based in the Netherlands. Despite the legal separation, both are Unilever. It maintains this dual headquarters arrangement and two tickers for a variety of reasons. Still, while UN faces higher dividend taxes, UL and UN remain almost identical for purposes of U.S. traders.Unilever owns a wide variety of consumer brands including Ben & Jerry's Ice Cream, Lipton Tea, Dove soap, and Axe skin products. In 2018, it derived about 60% of its revenue from personal products. The remainder came from packaged food-type products. It has undergone cost-cutting initiatives over the last few years and has aggressively moved into emerging markets.Over the long-term, UL and UN stock have generally risen, though it has stagnated over the last year. As of this writing, UN trades at about $57.50 per share, near its 52-week high. Still, both tickers support a forward P/E of about 20. Also, analysts expect an average 9.3% per year increase in profits over the next five years.For this reason, most of the benefit of owning UL and UN stock comes from the dividend. Since the company pays in pounds and euro, payouts may fluctuate. However, the stocks currently yield about 3.05%. Dividends also rise annually, at least when measured in the currency of their respective countries.Unilever may trade at a somewhat higher multiple compared to other personal products stocks. However, with its growing presence in emerging markets, both UN and UL stock can become a profitable growth and income play.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy for Spring Season Growth * This Is How You Beat Back a Bear Market * 7 Dental Stocks to Buy That Will Make You Smile Compare Brokers The post 3 Personal Products Stocks to Revitalize Your Portfolio appeared first on InvestorPlace.
- Markit•10 days ago
See what the IHS Markit Score report has to say about NU Skin Enterprises Inc.
NU Skin Enterprises Inc NYSE:NUSView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for NUS with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding NUS are favorable with net inflows of $71.55 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•11 days ago
Nu Skin Boasts Customer Growth, Faces Weak Gross Margin
Nu Skin (NUS) gains from an expanding customer base and prudent product launches. However, persistent decline in gross margin is a concern.
- Motley Fool•13 days ago
Why Nu Skin Enterpises Stock Dropped 20% in March
Investors got queasy after China ramped up scrutiny over sales of wellness products.
- Simply Wall St.•13 days ago
Why We Think Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Looking At
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Nu Skin Enterprises, Inc. (NYSE:NUS) is a stock with outstanding fundamental characteristics. When we build an inves...
- PR Newswire•21 days ago
Nu Skin Enterprises To Announce First-Quarter 2019 Results
PROVO, Utah , March 29, 2019 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) will release first-quarter results after the market closes on Tuesday, April 30 . The Nu Skin management team will host ...
- PR Newswire•22 days ago
Nu Skin introduces a Targeted Treatment for the Eye Area using ageLOC Lumispa's Exclusive Skin Refining Technology
Nu Skin's ageLOC LumiSpa Accent paired with ageLOC LumiSpa IdealEyes gently massages away the signs of stress and a busy lifestyle while reducing the appearance of puffiness, under-eye bags and dark circles ...
- InvestorPlace•23 days ago
10 F-Rated Stocks to Sell in This Narrow Market
The market took a tumble on Friday, with the Dow shedding more than 450 points. The pullback was largely due to the "inverted yield curve," which in the past has been a sign that a recession is on the horizon. So, investors panicked and looked for stocks to sell.Remember, an inverted yield curve is when short-term rates, like the three-month Treasury, move higher than the 10-year Treasury. This is exactly what happened on Friday. Not only that, but over in Europe, the German 10-year Bund yields slipped below 0%. This was due to a purchasing managers index (PMI) figure for the Eurozone that came in at the weakest reading in six years.Luckily, the Federal Reserve remains very sensitive to global events like slowing growth in China and Europe, as well as weaker economic data here in the United States. The Fed is anticipating 2.1% U.S. GDP growth in 2019, so it can afford to be patient moving forward. This is why they've tapped the brakes on raising key interest rates in 2019. And last Wednesday's dovish FOMC statement drove Treasury yields to their lowest level in the past 12 months.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAs a result, we experienced a five-basis-point Treasury yield curve inversion that spooked the stock market.Ultimately, the market was extremely overbought, so it was due for a breather. And the international flight to quality that's already underway -- due to the ongoing Brexit mess -- will continue to drive investors back to more domestic stocks with strong fundamentals. Lower Treasury yields are bullish for these stocks, which will attract money that's rotating out of bonds. * 7 Reasons to Buy Housing Stocks in 2019 However, I should add that these fundamentally superior stocks are growing increasingly scarce. The stock market is growing "narrower," especially with the 2019 pension funding season near an end and the first-quarter earnings season around the corner.Many multinational companies will struggle during this upcoming earnings season. This is mainly due to more difficult year-over-year comparisons. So, the narrow stock market will "funnel" money into more domestic stocks that can maintain strong sales and earnings.The bottom line: We are entering a stock pickers' market. So, it's more important than ever to stay laser-focused on stocks that can sustain strong earnings momentum.As for the ones that can't, well…look out below.My advice at this "fork in the road" is to purposefully avoid companies that simply don't measure up. And that's just the sort of assessment I designed my Portfolio Grader to do.Portfolio Grader assesses stocks on two key metrics: a Fundamental Grade and a Quantitative Grade.With the fundamentals, I want to see strong growth in sales, earnings and operating margins, as well as positive earnings surprises, upward revisions in Wall Street analyst's earnings forecasts, and strong cash flow, to name a few. Essentially, if a company is struggling to sell its products or is spending more than it makes, it's not a stock that you want to own for growth.That all being said -- I'm even more interested in a stock's Quantitative Grade. This basically tells us if it is experiencing strong buying pressure.When money is flooding into a stock, it gives it great momentum to rise going forward. So, I believe in "following the money" -- and these 10 are stocks to sell, as they are seeing extremely poor money flow, in addition to weak fundamentals: Stock RatingDean Foods (NYSE:DF) F Legg Mason (NYSE:LM) F Nomura Holdings (ADR) (NYSE:NMR) F Nu Skin Enterprises (NYSE:NUS) F Castle Brands (NYSEAMERICAN:ROX) F Ryanair Holdings Plc (ADR) (NASDAQ:RYAAY) F EchoStar (NASDAQ:SATS) F TiVo (NASDAQ:TIVO) F Tata Motors (ADR) (NYSE:TTM) F XPO Logistics (NYSE:XPO) F In the end, you'll find it's worthwhile to perform this "due diligence." And whether you're looking for stocks to buy or stocks to sell, my Portfolio Grader makes that simple and easy.Now, there are plenty that are seeing positive momentum -- in earnings/sales, as well as buying pressure. It's just important to find the right ones.The good news is that I've just recommended a stock for Accelerated Profits that knocks it out of the park in both respects. It's such a strong company that it holds the number-one ranking on my Accelerated Profits Buy List.This stock is still trading a little below my recommended buy limit, so now is the perfect time to check it out. If that interests you, click here to sign up and hear more.Louis Navellier is a renowned growth investor. He is the editor of four investing newsletters: Growth Investor, Breakthrough Stocks, Accelerated Profits and Platinum Growth. His most popular service, Growth Investor, has a track record of beating the market 3:1 over the last 14 years. He uses a combination of quantitative and fundamental analysis to identify market-beating stocks. Mr. Navellier has made his proven formula accessible to investors via his free, online stock rating tool, PortfolioGrader.com. Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Tech Stocks With Key Products That Face an Uncertain Future * 7 SaaS Stocks to Buy for Long-Term Gains * 5 Semiconductor Stocks That Are Scorching Hot Buys Compare Brokers The post 10 F-Rated Stocks to Sell in This Narrow Market appeared first on InvestorPlace.
- Associated Press•25 days ago
Viacom and Avaya Holdings rise, Nu Skin Enterprises slips
Stocks that moved substantially or traded heavily on Monday: Winnebago Industries Inc., down 10 cents to $29.01 The recreational vehicle company reported better-than-expected fiscal second-quarter profit. ...
- Benzinga•25 days ago
Stifel Downgrades Nu Skin To Sell Amid Chinese Clampdown On Direct Selling
The bearish sentiment toward Nu Skin reflected the uncertainty surrounding direct selling companies in China against the backdrop of an investigation announced early January into the unlawful promotion and sale of health products, leading up to a 100-day ban on business meetings, Astrachan said in a note. This, along with the recent death of the company's registered customer in China, has elicited strong reactions from two communist party publications, one of which called for an investigation into the death and the company's misleading advertising.
- TheStreet.com•25 days ago
Nu Skin's Stock Price Shrivels After Negative Analyst Report
Nu Skin's stock price dropped 7.31% to $45.68 after the downgrade by Stifel Nicolaus analyst Mark Astrachan, who pointed to the potential of increased regulatory scrutiny in China into direct sales companies like Nu Skin, which focuses on wellness and beauty. The Chinese government launched a 100-day investigation on Jan. 8 into direct sales companies following the death of a 7-year-old cancer patient who was given an herb product touted as having anti-cancer powers instead of traditional medicine. Licenses required for direct sales companies like Nu Skin to do business have been suspended by the Chinese government during the investigation, as well a business meetings.
- MarketWatch•25 days ago
Nu Skin's stock extends tumble toward 2-year low after Stifel analyst turns bearish
Shares of Nu Skin Enterprises Inc. sank 2.6% toward a fresh 2-year low in premarket trade Monday, adding to the 17% plunge over the previous five sessions, after Stifel Nicolaus analyst Mark Astrachan turned bearish on the direct seller of beauty and wellness products, citing increasing China uncertainty. Astrachan cut his rating back to sell, after upgrading it to hold in August, and slashed his price target to $43 from $63. The downgrade comes after China announced an investigation into direct selling companies and the unlawful promotion and sale of health products, which resulted in a 100-day ban on business meetings. Astrachan noted that recently a Nu Skin customer had died, after refusing medical treatment because they believed the company's products would treat their illness. "While the investigation does not yet specifically pertain to Nu Skin, we view increased scrutiny of the direct selling industry broadly and Nu Skin specifically as likely to impact category and company recruitment, negatively impacting sales and profit in a key market," Astrachan wrote in a note to clients. The stock has tumbled 19.7% year to date through Friday, while the S&P 500 has gained 11.7%.
GuruFocus.com•28 days agoRisk-Reward With Nu Skin Enterprises
When it comes to beauty products, worldwide consumption has a virtually bottomless appetite. Almost any female social media "influencer" pushes some version of health or beauty product, either their own (e.g., Kylie Jenner) or any one of the plethora of new and old brands on the market. Nu Skin Enterprises Inc. (NUS) has a hybrid model, somewhere between direct-selling and online retail, offering a broad array of branded health and beauty products in more than 50 countries across Europe, the Asia-Pacific and the Americas.
- Zacks•29 days ago
Estee Lauder's Buyouts & Robust Online Business Bode Well
Estee Lauder's (EL) solid focus on buyouts, travel retail network, effective launches and strong online sales are impressive.
- Zacks•last month
NUS vs. IPAR: Which Stock Is the Better Value Option?
NUS vs. IPAR: Which Stock Is the Better Value Option?
- Zacks•last month
Can Value Investors Consider Nu Skin (NUS) Stock Now?
Nu Skin (NUS) stock may be a good choice for value-oriented investors right now from multiple angles.
- Simply Wall St.•last month
Should Investors Be Happy About Nu Skin Enterprises, Inc.’s (NYSE:NUS) Cash Levels?
If you are currently a shareholder in Nu Skin Enterprises, Inc. (NYSE:NUS), or considering investing in the stock, you need to examine how the business generates cash, and how itRead More...
- Zacks•2 months ago
Zacks.com featured highlights include: Materion, Boston Beer , Nu Skin, Darden and Comfort Systems
Zacks.com featured highlights include: Materion, Boston Beer , Nu Skin, Darden and Comfort Systems
- Zacks•2 months ago
Coty Picks Up Steam, Stock Rallies 59% Since Q2 Results
Coty's (COTY) Luxury unit continues to deliver a strong show. Also, acquisitions and e-commerce efforts bode well amid hurdles like soft Consumer Beauty segment.
- Zacks•2 months ago
Will Strong Demand Fuel United Natural's (UNFI) Q2 Earnings
United Natural's (UNFI) Q2 results to gain from robust demand conditions and buyouts. However, rising fright costs and unfavorable consumer mix are concerns.
- GlobeNewswire•2 months ago
Recent Analysis Shows McDermott International, Nu Skin Enterprises, Marcus, Keysight Technologies, Alder BioPharmaceuticals, and LendingTree Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, March 01, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
- Zacks•2 months ago
What Bargain Hunting? Bet on 5 Stocks With Rising P/E
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
- PR Newswire•2 months ago
Nu Skin Unveils Strategy To Sustainably Source Its Own Pure, Traceable Ingredients
PROVO, Utah, Feb. 28, 2019 /PRNewswire/ -- As part of its annual investor day, Nu Skin Enterprises, Inc. today shared its long-term strategy for consistently sourcing pure, safe and effective ingredients for use in its products. To accomplish this, Nu Skin plans to build on its investment in Controlled Environment Agriculture (CEA) technologies to develop sustainable ingredients that are traceable from seed to solution. Nu Skin's CEA strategy grows out of a desire to provide consumers safe, effective and traceable product ingredients while drastically reducing the land and water resources required.
